KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Liabilities and Shareholders Equity (2016 - 2025)

Evolent Health has reported Liabilities and Shareholders Equity over the past 12 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $1.9 billion for Q4 2025, down 25.36% from a year ago — trailing twelve months through Dec 2025 was $9.5 billion (down 6.86% YoY), and the annual figure for FY2025 was $1.9 billion, down 25.36%.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.9 billion at Evolent Health, down from $2.5 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for EVH hit a ceiling of $2.7 billion in Q4 2023 and a floor of $1.3 billion in Q3 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $2.5 billion (2025), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 102.99% in 2023 and later fell 25.36% in 2025.
  • Evolent Health's Liabilities and Shareholders Equity stood at $1.4 billion in 2021, then rose by 28.03% to $1.8 billion in 2022, then skyrocketed by 47.49% to $2.7 billion in 2023, then dropped by 5.07% to $2.5 billion in 2024, then dropped by 25.36% to $1.9 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $1.9 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025) per Business Quant data.